Virtu Financial LLC Context Therapeutics Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$0.56 - $1.06 $9,107 - $17,239	-16,264 Reduced 28.31%	41,191 $23,000
Q4 2022 Feb 15, 2023	BUY	$0.61 - $1.42 $35,047 - $81,586	57,455 New	57,455 $38,000
Q2 2022 Aug 09, 2022	BUY	$1.29 - $2.66 $59,914 - $123,543	46,445 New	46,445 $98,000
Q1 2022 May 17, 2022	SELL	$1.72 - $2.82 $92,056 - $150,929	-53,521 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.66 - $7.45 $142,365 - $398,731	53,521 New	53,521 $142,000

56.9M

Ticker CNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,966,100
Market Cap $29.4M
Description
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.